Stereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patients

Neoplasma

Volumn 59, Issue 1, 2012, Pages 114-120

  Dworzecki, T ^a   Idasiak, A ^a   Sygula, D ^a   Dworzecka, U ^a   Suwinski, R ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Lung cancer; Reirradiation; Stereotactic body irradiation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMOTHERAPY; COMPARATIVE STUDY; DISTANT FAILURE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRRADIATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; RADIATION DOSE; SALVAGE THERAPY; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; ADENOCARCINOMA; DISEASE FREE SURVIVAL; DYSPNEA; EVALUATION; KAPLAN MEIER METHOD; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; PATHOLOGY; POSTOPERATIVE COMPLICATION; RADIOSURGERY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84863750170     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2012_015     Document Type: Article

References (22)

1. SAYNAK M, VEERAMACHANENI NK, HUBBS JL, NAM J, QAQISH BF et al. Local Failure after complete resection of N0-1 non-small cell lung cancer. Lung Cancer 2011; 71: 156-165. http://dx.doi.org/10.1016/j.lungcan.2010.06.001
2. SUGI K, KOBAYASHI S, SUDOU M, SAKANO H, MATSUDA E et al. Long-term prognosis of video-assisted limited surgery for early lung cancer. Eur J Cardiothorac Surg 2010; 37: 456-460
3. SURA S, GUPTA V, YORKE E, JACKSON A, AMOLS H et al. Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: The Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol 2008; 87: 17-23 http://dx.doi.org/10.1016/j.radonc.2008.02.005
4. FANG LC, KOMAKI R, ALLEN P, GUERRERO T, MOHAN R et al. Comparison of outcomes for patients with medically inoperable Stage I nonâ"small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66: 108-116 http://dx.doi. org/10.1016/j.ijrobp.2006.04.015
5. BRADLEY JD, MOUGHAN J, GRAHAM MV, BYHARDT R, GOVINDAN R et al. A Phase I/II Radiation Dose Escalation Study With Concurrent Chemotherapy for Patients With Inoperable Stages I to III Non-Small-Cell Lung Cancer: Phase I Results of RTOG 0117. Int J Radiat Oncol Biol Phys 2010; 77: 367-372. http://dx.doi.org/10.1016/j.ijrobp.2009.04.029
6. DE RUYSSCHER D, WANDERS R, VAN HAREN E, HOCHSTENBAG M, GERAEDTS W et al. HI-CHART: A Phase I/II Study on the Feasibility of High-Dose Continuous Hyperfractionated Accelerated Radiotherapy in Patients With Inoperable Non-Small-Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2008; 71: 132-138. http://dx.doi.org/10.1016/j.ijrobp.2007.09.048
7. BBELDERBOS JS, HEEMSBERGEN WD, DE JAEGER K, BAAS P, LEBESQUE JV et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66: 126-134. http://dx.doi.org/10.1016/j.ijrobp.2006.04.034
8. SUWINSKI R, TAYLOR JM, WITHERS HR The effect of heterogeneity in tumor cell kinetics on radiation doseresponse. An exploratory investigation of plateau effect. Radiother Oncol 1999; 50: 57-66. http://dx.doi.org/10.1016/S0167-8140(99)00014-6
9. CHI A, LIAO Z, NGUYEN NP, XU J, STEA B et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications Radiother Oncol 2010; 94: 1-11. http://dx.doi.org/10.1016/j.radonc.2009.12.008
10. TIMMERMAN RD, PAULUS R, GALVIN J, MICHALSKI J, STRAUBE W et al. Stereotactic Body Radiation Therapy for Medically Inoperable Early-stage Lung Cancer Patients: Analysis of RTOG 0236. Int J Radiat Oncol Biol Phys 2009; 75: S3. http://dx.doi.org/10.1016/j.ijrobp.2009.07.033
11. MCGARRY RC, PAPIEZ L, WILLIAMS M, WHITFORD T, TIMMERMAN RD et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005; 63: 1010-1015. http://dx.doi. org/10.1016/j.ijrobp.2005.03.073
12. TIMMERMAN R, MCGARRY R, YIANNOUTSOS C, PAPIEZ L, TUDOR K et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833-4839. http://dx.doi.org/10.1200/JCO.2006.07.5937
13. JOYNER M, SALTER BJ, PAPANIKOLAOU N, FUSS M Stereotactic body radiation therapy for centrally located lung lesions, Acta Oncol 2006; 45: 802-7. http://dx.doi.org/10.1080/02841860600915322
14. SALAZAR OM, SANDHU TS, LATTIN PB, CHANG JH, LEE CK et al. Once-weekly, high-dose stereotactic body radiotherapy for lung cancers: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastaic lung cancers. Int J Radiat Oncol Biol Phys 2008; 72: 707-715. http://dx.doi.org/10.1016/j.ijrobp.2008.01.054
15. CHEN Y, GUO W, LU Y, ZOU B Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy. Radiother Oncol 2008; 88: 351-8. http://dx.doi. org/10.1016/j.radonc.2008.07.013
16. SUWINSKI R, SLOSAREK K, RUTKOWSKI R, GRZADZIEL A, KOWALSKI A Implementing 4D radiotherapy into clinical practice: the applications of respiratory gated stereotactic radiosurgery for lung tumors. Nowotwory. Journal of Oncology 2006; 56: 242-248
17. JOINER M, VAN DER KOGEL A Basic Clinical Radiobiology. London: Hodder Arnold, 2009.
18. WITHERS HR, TAYLOR JM, MACIEJEWSKI B The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-146. http://dx.doi. org/10.3109/02841868809090333
19. BABA F, SHIBAMOTO Y, OGINO H, MURATA R, SUGIE C et al. Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size. Radiation Oncology 2010: 5: 81 http://dx.doi.org/10.1186/1748-717X-5-81
20. WULF J, BAIER K, MUELLER G, FLENTJE MP Dose-Response in stereotactic irradiation of lung tumors. Radiother Oncol 2005; 77: 83-87. http://dx.doi.org/10.1016/j.radonc.2005.09.003
21. WERNER-WASIK M, SWANN RS, BRADLEY J, GRAHAM M, EMAMI B et al. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the radiation therapy oncology group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 70: 385-390. http://dx.doi.org/10.1016/j.ijrobp.2007.06.034
22. DUNLAP NE, LARNER JM, READ WP, KOZOWER BD, LAU CL et al. Size matters: A comparison of T1 and T2 peripheral non-small-cell lung cancer treated with stereotactic body radiation therapy (SBRT). J. Thorac. Cardiovasc. Surg. 2010; 140: 583-589. http://dx.doi.org/10.1016/j.jtcvs.2010.01.046